| 000 | 01622 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515100108.0 | ||
| 264 | 0 | _c20080514 | |
| 008 | 200805s 0 0 eng d | ||
| 022 | _a0007-1188 | ||
| 024 | 7 |
_a10.1038/sj.bjp.0707621 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLeón, H | |
| 245 | 0 | 0 |
_aInhibition of matrix metalloproteinases prevents peroxynitrite-induced contractile dysfunction in the isolated cardiac myocyte. _h[electronic resource] |
| 260 |
_bBritish journal of pharmacology _cFeb 2008 |
||
| 300 |
_a676-83 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 | _aCardiac Pacing, Artificial |
| 650 | 0 | 4 |
_aDoxycycline _xpharmacology |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 | _aHomeostasis |
| 650 | 0 | 4 |
_aHydroxamic Acids _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 2 _xmetabolism |
| 650 | 0 | 4 | _aMatrix Metalloproteinase Inhibitors |
| 650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
| 650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
| 650 | 0 | 4 |
_aOligopeptides _xpharmacology |
| 650 | 0 | 4 |
_aPeroxynitrous Acid _xmetabolism |
| 650 | 0 | 4 |
_aProtease Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aBaczkó, I | |
| 700 | 1 | _aSawicki, G | |
| 700 | 1 | _aLight, P E | |
| 700 | 1 | _aSchulz, R | |
| 773 | 0 |
_tBritish journal of pharmacology _gvol. 153 _gno. 4 _gp. 676-83 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bjp.0707621 _zAvailable from publisher's website |
| 999 |
_c17584986 _d17584986 |
||